Left ventricular lead implantation at a phrenic stimulation site is safe and effective

Europace

Volumn 13, Issue 4, 2011, Pages 520-525

  Jastrzebski, Marek ^a   Bacior, Bogumiła ^b   Wojciechowska, Wiktoria ^b   Czarnecka, Danuta ^b  

^a UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Cardiac resynchronization therapy; Diaphragmatic pacing; Heart failure; Pacing complications; Phrenic stimulation

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE; HUMAN; IMPLANTATION; LEFT VENTRICULAR LEAD IMPLANTATION; MAJOR CLINICAL STUDY; MALE; NERVE STIMULATION; OUTCOME ASSESSMENT; PATIENT SAFETY; PHRENIC NERVE; PRIORITY JOURNAL; REOPERATION;

ADULT; AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; ELECTROCARDIOGRAPHY; ELECTRODES, IMPLANTED; FEMALE; HEART FAILURE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHRENIC NERVE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 79953769963     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq505     Document Type: Article

References (18)

1. Sanchez-Quintana D, Cabrera JA, Climent V, Farre J, Weiglein A, Ho SY. How close are the phrenic nerves to cardiac structures? Implications for cardiac interventionalists. J Cardiovasc Electrophysiol 2005;16:309-13. (Pubitemid 40404598)
2. Biffi M, Moschini C, Bertini M, Saporito D, Ziacchi M, Diemberger I et al. Phrenic stimulation: a challenge for cardiac resynchronization therapy. Circ Arrhythm Electrophysiol 2009;2:402-10.
3. Gras D, Bocker D, Lunati M, Wellens HJ, Calvert M, Freemantle N et al. Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Europace 2007;9:516-22. (Pubitemid 47249440)
4. Ypenburg C, van Bommel RJ, Delgado V, Mollema SA, Bleeker GB, Boersma E et al. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol 2008;52:1402-9.
5. Ypenburg C, van Bommel RJ, Borleffs CJ, Bleeker GB, Boersma E, Schalij MJ et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol 2009;53:483-90.
6. Leclercq C, Mabo P, Daubert JC. Troubleshooting. In: Yu C.M, Hayes DL, Auricchio A (eds). Cardiac Resynchronization Therapy. 1st ed. Malden: Blackwell Publishing Futura, 2006. p259-90.
7. Sweeney MO. Programming and follow-up of cardiac resynchronization devices. In: Ellenbogen KA, Kay GN, Lau CP, Wilkoff BL. (eds). Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy. 3rd ed. Philadelphia: Saunders, 2007. p1087-140.
8. Sweeney MO. Implantation techniques for cardiac resynchronization therapy. In: Yu CM, Hayes DL, Auricchio A. (eds). Cardiac Resynchronization Therapy. 1st ed. Malden: Blackwell Futura, 2006. p175-210.
9. Seifert M, Schau T, Moeller V, Neuss M, Meyhoefer J, Butter C. Influence of pacing configurations, body mass index, and position of coronary sinus lead on frequency of phrenic nerve stimulation and pacing thresholds under cardiac resynchronization therapy. Europace 2010;12:961-7.
10. Gurevitz O, Nof E, Carasso S, Luria D, Bar-Lev D, Tanami N et al. Programmable multiple pacing configurations help to overcome high left ventricular pacing thresholds and avoid phrenic nerve stimulation. Pacing Clin Electrophysiol 2005;28:1255-9. (Pubitemid 43951384)
11. Forleo GB, Della Rocca DG, Papavasileiou LP, Molfetta AD, Santini L, Romeo F. Left ventricular pacing with a new quadripolar transvenous lead for CRT: early results of a prospective comparison with conventional implant outcome. Heart Rhythm 2011;8:31-37.
12. Thibault B, Karst E, Ryu K, Paiement P, Farazi TG. Pacing electrode selection in a quadripolar left heart lead determines presence or absence of phrenic nerve stimulation. Europace 2010;12:751-3.
13. Biffi M, Bertini M, Saporito D, Ziacchi M, Stabellini S, Valsecchi S et al. Automatic management of left ventricular stimulation: hints for technologic improvement. Pacing Clin Electrophysiol 2009;32:346-53.
14. Worley SJ. Left ventricular lead implantation. In: Ellenbogen KA, Kay GN, Lau CP, Wilkoff BL (eds). Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy. 3rd ed. Philadelphia: Saunders Elsevier, 2007. p653-826.
15. MADIT-CRT: Avoid apical LV lead position in HF resynchronization therapy. http://www.theheart.org/article/1078227.do
16. Leon AR, Abraham WT, Curtis AB, Daubert JP, Fisher WG, Gurley J et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol 2005;46:2348-56. (Pubitemid 41785509)
17. Alonso C, Leclercq C, d' Allonnes FR, Pavin D, Victor F, Mabo P et al. Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects. Heart 2001;86:405-10.
18. Worley SJ. CRT delivery systems based on guide support for LV lead placement. Heart Rhythm 2009;6:1383-7.